<?xml version="1.0" encoding="UTF-8"?>
<p>Baricitinib is a drug used basically for the treatment of rheumatoid arthritis. It acts as an inhibitor for Janus kinase (JAK, U.S. Food and Drug Administration, 2018). Inhibition of the JAK pathway might interrupt the virus entry and the virions intracellular assembly by interfering with the endocytosis process [
 <xref rid="B42-pathogens-09-00331" ref-type="bibr">42</xref>].
</p>
